Advertisement

Hospital survey of antimicrobial prophylaxis to prevent endocarditis in patients with prosthetic heart valves

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The American Heart Association (AHA) has published guidelines for use of prophylactic antibiotics to prevent bacterial endocarditis, but few data are available about physician compliance with these guidelines. A retrospective review was conducted of the use of prophylactic antibiotics in patients with prosthetic heart valves who were undergoing diagnostic or operative procedures or heart catheterization at three hospitals. Compliance with AHA recommendations was only 30 percent (14 of 46) for procedures considered high risk for patients with prosthetic heart valves. Six (23 percent) of 26 patients who underwent right or left heart catheterization received prophylactic antibiotics (not recommended by AHA). Antibiotics were given to 42 (74 percent) of 57 patients who underwent surgical procedures considered at low risk of bacteremia, but only 33 (58 percent) received antibiotics that cover organisms commonly present at the site of the procedure. The results indicate that clinicians frequently do not administer prophylactic antibiotics in patients with prosthetic heart valves who are undergoing invasive procedures or do not follow published AHA guidelines when antibiotics are administered.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Committee on Rheumatic Fever and Bacterial Endocarditis of the Council on
        • Cardiovascular Disease in the Young of the American Heart Association
        Prevention of bacterial endocarditis.
        Circulation. 1977; 56 (suppl): 139A-143A
        • Shulman ST
        • Amren DP
        • Bisno AL
        • et al.
        Prevention of bacterial endocarditis.
        in: A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Diseases in the Young. Circulation. 70. 1984: 1123A-1127A
      1. J Am Dent Assoc. 1977; 95: 600-605
        • Durack DT
        Current practice in prevention of bacterial endocarditis.
        Br Heart J. 1975; 37: 478-481
        • Durack DT
        • Kaplan EL
        • Bisno AL
        Apparent failures of endocarditis prophylaxis.
        in: Analysis of 52 cases submitted to a national registry. JAMA. 1983: 2318-2322
        • Brooks S
        Survey of compliance with American Heart Association guidelines for prevention of bacterial endocarditis.
        J Am Dent Assoc. 1980; 101: 41-43
        • Rossiter SJ
        • Stinson EB
        • Oyer PE
        • et al.
        Prosthetic valve endocarditis.
        in: Comparison of heterograft tissue valves and mechanical valves. J Thor Cardiovasc Surg. 76. 1978: 795-802
        • Kloster FE
        Diagnosis and management of complications of prosthetic heart valves.
        Am J Cardiol. 1975; 35: 872-885
        • Durack DT
        Current issues in prevention of infective endocarditis.
        Am J Med. 1985; 78: 149-156
        • Everett ED
        • Hirschmann JV
        Transient bacteremia and endocarditis prophylaxis: a review.
        Medicine (Baltimore). 1977; 56: 61-77
        • Durack DT
        • Petersdorf RG
        Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.
        J Clin Invest. 1973; 52: 592-598
        • Farber BF
        • Moellering RC
        Retrospective study of the toxicity of preparations of vancomycin from 1974–1981.
        Antimicrob Agents Chemother. 1983; 23: 138-141
        • Durack DT
        Prophylaxis of infective endocarditis.
        in: Mandell GL Douglas Jr, RG Bennett JE Principles and practice of infectious diseases. John Wiley, New York1985: 539-544